My COVID-19 Vaccine Experience, Part 1: Expectations and Frustrations

Columns, Intestinal Fortitude - a Column by Emmeline Olson

First in a series. On Dec. 11, after I had spent more than 80% of 2020 at home, the door to normalcy cracked open. That day, the U.S. Food and ... Read more

January 18, 2021January 18, 2021

Risankizumab for 12 Weeks Leads to Remission in Crohn’s Trials

Crohn's Disease, News

Treatment with risankizumab for 12 weeks (three months) induced both clinical and endoscopic remission in people with Crohn’s disease, a type of inflammatory bowel disease (IBD), new Phase 3 clinical ... Read more

January 14, 2021January 12, 2021

Nurturing Hope in 2021 With Fertilizer From 2020

Columns, Intestinal Fortitude - a Column by Emmeline Olson

Along with the rest of the world, I’m forging ahead into 2021, making 2020 a distant memory. I thought 2020 would be a year to remember. I had a new ... Read more

January 11, 2021January 11, 2021

Clinical Benefits of ABX464 for Ulcerative Colitis Revealed in Review Study

IBD News, News, Ulcerative colitis

Abivax has published a review study summarizing the mechanisms, as well as the previously undisclosed clinical benefits of ABX464, its treatment candidate for people with inflammatory diseases, including ulcerative colitis ... Read more

January 7, 2021January 5, 2021

Finding a Remedy When Remicade Stops Working

Columns, Intestinal Fortitude - a Column by Emmeline Olson

Since September, I’ve been getting Remicade (infliximab) infusions every four weeks. My gastroenterologist changed my schedule from every eight weeks after my colonoscopy in August showed I was no longer ... Read more

January 4, 2021January 4, 2021

EU Reviewing Zeposia as Ulcerative Colitis Treatment for Adults

IBD News, News, Ulcerative colitis

The anti-inflammatory medication Zeposia (ozanimod) is under review in the European Union as a treatment for adults with moderately to severely active ulcerative colitis. The European Medicines Agency has validated ... Read more

December 21, 2020December 21, 2020

Rinvoq Found Safe, Effective for Ulcerative Colitis in Ongoing Phase 3 Trial

News, Ulcerative colitis

Rinvoq (upadacitinib), AbbVie‘s investigational anti-inflammatory medicine, was found to be safe and effective in treating adults with moderate-to-severe ulcerative colitis (UC). The medication met all major endpoints in an ongoing ... Read more

December 21, 2020December 21, 2020

Abivax Completes Enrollment in ABX464 Trial for Ulcerative Colitis

News, Ulcerative colitis

Abivax has completed patient enrollment, ahead of schedule and despite the COVID 19 pandemic, in its Phase 2b trial evaluating ABX464 as a treatment candidate for people with moderate-to-severe ulcerative ... Read more

December 17, 2020December 14, 2020

Chicken Soup for the Soul and IBD Symptoms

Columns, Intestinal Fortitude - a Column by Emmeline Olson

A few weeks ago, I mentioned that a lot of Filipino cuisine I grew up eating soothed my Crohn’s symptoms. A comfort food that my mother makes for me whenever ... Read more

December 10, 2020December 8, 2020

A Week of Worry: COVID-19 Hits Home

Columns, Intestinal Fortitude - a Column by Emmeline Olson

Before Thanksgiving, I wrote about finding thanks in the chaos of COVID-19. As I submitted my column for publication, the pandemic hit home. Fear and uncertainty quickly replaced gratitude. Since ... Read more